SM(d34:2)

Metabolite details

Identifier

KWBUHXGHUWSKEX-QPPIDDCLSA-N

InChI Key

KWBUHXGHUWSKEX-QPPIDDCLSA-N

IUPAC name

[(2S,3R)-2-(hexadec-3-enoylamino)-3-hydroxyoctadec-5-enyl] 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

SM(d34:2)

INN name

—

Synonym

—

ChEBI

CHEBI:190215

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity

Observed in differential profiles

• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Control_vs_Palmitate